Dcp1 Activators
Dcp1, pivotal for mRNA decapping, regulates mRNA stability and subsequent protein synthesis. Its indirect modulation stems from influencing the broader landscape of mRNA metabolism. Chemicals such as Actinomycin D and Cordycepin, which halt RNA synthesis, emphasize the cellular demand for mRNA degradation, potentiating the role of Dcp1. Similarly, Amanitin's inhibition of RNA polymerase II underscores the need for balanced mRNA degradation, where Dcp1 is inevitably engaged.
Leptomycin B and DRB, by impacting nuclear export and transcription elongation respectively, alter the cellular mRNA dynamics, making the degradation pathway more essential, consequently spotlighting Dcp1's functionality. On the other hand, translation like Puromycin accentuate the presence of truncated mRNAs. The cell responds by upregulating degradation pathways, indirectly pushing Dcp1 into action. Staurosporine, a broad-spectrum kinase, and Chloroquine, known for its effects on endosomal pH, influence a spectrum of cellular events. Any disruption in cellular equilibrium can reverberate through mRNA metabolism, presenting points of modulation for Dcp1. In this matrix of cellular RNA metabolism, chemicals influencing transcription, translation, or even broader cellular pathways can channel their effects, directly or indirectly, towards modulating Dcp1, underscoring the intricate interconnectedness of cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Cordycepin is an adenosine analogue that terminates mRNA synthesis. Stunted mRNA synthesis emphasizes the mRNA degradation process, potentially elevating Dcp1's role. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB is a CDK9 inhibitor, halting the elongation phase of transcription. This inhibition stresses mRNA degradation, potentially activating Dcp1. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine interferes with multiple cellular processes, including mRNA metabolism. This interference can indirectly influence Dcp1 function in mRNA degradation. | ||||||
Polymyxin B Sulfate | 1405-20-5 | sc-3544 | 500 mg | $63.00 | 8 | |
Polymyxin B impacts RNA metabolism. Any shift in RNA metabolism can potentially modulate pathways where Dcp1 is active. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent protein kinase inhibitor, Staurosporine can affect multiple pathways, including those related to mRNA life cycle, thus indirectly modulating Dcp1. | ||||||
Sinefungin | 58944-73-3 | sc-203263 sc-203263B sc-203263C sc-203263A | 1 mg 100 mg 1 g 10 mg | $271.00 $5202.00 $40368.00 $704.00 | 4 | |
Sinefungin inhibits methyltransferases, which can have downstream effects on mRNA cap structures, potentially affecting Dcp1 function. | ||||||
Myriocin (ISP-1) | 35891-70-4 | sc-201397 | 10 mg | $150.00 | 8 | |
Myriocin impacts sphingolipid metabolism which can indirectly influence various cellular pathways including mRNA degradation and thus Dcp1. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine alters endosomal pH, affecting many cellular processes. Any major shift in cellular homeostasis can have implications on mRNA degradation, potentially influencing Dcp1. | ||||||